home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
TIME: Almanac 1990
/
1990 Time Magazine Compact Almanac, The (1991)(Time).iso
/
time
/
091189
/
09118900.022
< prev
next >
Wrap
Text File
|
1990-09-17
|
883b
|
16 lines
BUSINESS, Page 59Business NotesPHARMACEUTICALSThe Capsules That Flunked
At first the growing generic drug-industry scandal was limited
to a few unscrupulous newcomers. But last week the Government's
probe of substandard generics struck an industry leader, Bolar
Pharmaceutical of Copiague, N.Y. The Food and Drug Administration
said that it intends to withdraw its approval of Bolar's generic
version of Dyazide, the top-selling brand-name hypertension drug.
Reason: the FDA says it can no longer be sure that the generic is
biologically equivalent to its brand-name counterpart. After
reviewing Bolar's records, the FDA found that the company had
submitted two batches of its drug for approval in 1987. Only one
passed the equivalency test, but it is unclear which version
reached the market. Bolar claims that only the effective generic
is in drugstores.